InforMedix Holdings, Inc. (OTCBB: IFMX), creating a new technology platform that improves medication adherence and enables patients to manage chronic illnesses at home, today announced plans that its patented Med-eMonitor(TM) System will be used to improve the monitoring and care of 200 schizophrenic patients in San Antonio, Texas.
